Germany – Pharmaceuticals – Pharmaceutical Agreements with Accession Option
Deutschland – Arzneimittel – Arzneimittelverträge mit Beitrittsoption
Germany · Wuppertal
What the buyer is looking for
Vertragsgegenständlich sind Arzneimittel, die den Wirkstoff Lanreotid enthalten.
Description as published (DE).
Contract
BuyerBARMER Beschaffung und Vergabe
TypeSupplies
Estimated value33.819.814 €
Published18 February 2026
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| AMAROX PHARMA GmbH · Haar | 6 | 2025–2026 |
| Zentiva Pharma GmbH · Frankfurt am Main | 5 | 2025–2026 |
| T-Systems International GmbH · Düsseldorf | 5 | 2024–2025 |
| Adesso SE | 4 | 2026 |
| init AG | 4 | 2025–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
202434
202588
20252
202667
Who knows the rhythm prepares instead of reacting.
530
days until the deadline — Tuesday 1 February at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →